Skip to main content

Idaho Tech Licenses PCR Patent From Utah Research Foundation

NEW YORK (GenomeWeb News) — Idaho Technology today said it has licensed PCR-amplification technology from Utah Research Foundation.
Idaho Tech said it has retained exclusive rights to the university’s Patent No. 7,160,998, entitled "Monitoring Amplification with FRET Probes,” which covers real-time PCR amplification kits using two DNA probes labeled with fluorescent molecules.
When these probes are hybridized to specific regions of DNA they create a fluorescent resonance energy transfer, or FRET, according to Idaho Tech.
Idaho Tech said it will use the technology in freeze-dried reagents that detect pathogens on its Ruggedized Advanced Pathogen Identification Device and Roche’s LightCycler instrument.
Financial terms of the license were not released.
On Jan. 5 Idaho Tech licensed PCR patents from Roche that it plans to use in its in vitro diagnostic products.
Six days later the company pocketed $3.5 million from Cephied as part of a settlement and a cross-licensing agreement that resolved a 2005 suit alleging that Cepheid infringed three PCR-related patents.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.